‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

Author: The Guardian

Date: 6/17/25

Language: English

Learn More: https://www.theguardian.com/society/2025/jun/17/hiv-ending-drug-lenacapavir-manufacture-cost-per-patient-gilead

You might also enjoy

FINALLY, THE PANDEMIC AGREEMENT!!! …… Many missed opportunities, but a beginning made

Findings from T1International’s 2024 Out-of-Pocket Expenses and Rationing Survey

Free trade agreement with Malaysia: Switzerland imperils the rights to food and health

Making Access to Quality Healthcare a Top Priority for the EU

Against the normalization of limited access to CAR-T cell therapies

If Not Now, Then When? Reimagining Global Health Equity